Business● LowSep 21 · Sep 21, 2026, 5:06 PM
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
GlobeAlert Desk · curated from CNBC · global
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business21m agoThe viral winter coat on Oprah’s Favorite Things List last year is on sale ahead of Black FridayNY Post · United StatesBusiness22m agoTwo Chinese citizens arrested in Ezeiza with almost five kilos of gold powder before traveling to DubaiInfobae · ArgentinaBusiness23m agoEldorado Gold pitched as long idea by XIB at C4K Investors ConferenceSeeking Alpha TechBusiness23m agoToyota Tacoma made in Argentina will be sold in BrazilG1 · Brazil